Common variation in with no-lysine kinase 1 (WNK1) and blood pressure responses to dietary sodium or potassium interventions: Family-based association study

Circulation Journal

Volumn 77, Issue 1, 2013, Pages 169-174

  Liu, Fuqiang ^a,b   Zheng, Shuhui ^a,b   Mu, Jianjun ^a,b   Chu, Chao ^a,b   Wang, Lan ^a,b   Wang, Yang ^a,b   Xiao, Hongyu ^a,b   Wang, Dan ^a,b   Cao, Yu ^a,b   Ren, Keyu ^a,b   Liu, Enqi ^c,d   Yuan, Zuyi ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Blood pressure; Gene polymorphism; Potassium; Sodium; With no lysine kinase 1 (WNK1)

Indexed keywords

PROTEIN KINASE WNK1;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; DNA EXTRACTION; FEMALE; FLAME PHOTOMETRY; GENE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POTASSIUM INTAKE; POTASSIUM URINE LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; WITH NO LYSINE KINASE 1 GENE;

ADOLESCENT; ADULT; BLOOD PRESSURE; FAMILY; FEMALE; HUMANS; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHLORIDE; PROTEIN-SERINE-THREONINE KINASES; SODIUM CHLORIDE, DIETARY;

EID: 84871680316     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0900     Document Type: Article

References (30)

1. World Health Organization. World Health Report 2002: Reducing risks, promoting healthy life. Geneva: World Health Organization, 2002.
2. Lewington S. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
3. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.
4. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 1629-1641.
5. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003; 139: 761-776.
6. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation: Pathogenesis of hypertension and therapeutic aspects. Circ J 2010; 74: 827-835.
7. Hiura Y, Tabara Y, Kokubo Y, Okamura T, Miki T, Tomoike H, et al. A genome-wide association study of hypertension-related phenotypes in a Japanese population. Circ J 2010; 74: 2353-2359.
8. Muntzel M, Drüeke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992; 5: 1S-42S.
9. He FJ, MacGregor GA. Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol 2007; 22: 298-305.
10. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: A metaregression analysis of randomised trials. J Hum Hypertens 2003; 17: 471-480.
11. Mu J, Liu Z, Liu F, Xu X, Liang Y, Zhu D. Family-based randomized trial to detect effects on blood pressure of a salt substitute containing potassium and calcium in hypertensive adolescents. Am J Hypertens 2009; 22: 943-947.
12. Khaw KT, Barrett-Connor E. The association between blood pressure, age, and dietary sodium and potassium: A population study. Circulation 1988; 77: 53-61.
13. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27: 481-490.
14. Chen J. Sodium sensitivity of blood pressure in Chinese populations. Curr Hypertens Rep 2010, 12: 127-134.
15. He J, Gu DF, Kelly TN, He J, Hixson JE, Rao DC, et al. Genetic variants in the renin-angiotensin-aldosterone system and blood pressure responses to potassium intake. J Hypertens 2011; 29: 1719-1730.
16. Naray-Fejes-Toth A, Snyder PM, Fejes-Toth G. The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport. Proc Natl Acad Sci USA 2004; 101: 17434-17439.
17. Kahle KT, Ring AM, Lifton RP. Molecular physiology of the WNK kinases. Annu Rev Physiol 2008; 70: 329-355.
18. Huang CL, Kuo E. Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol 2007; 11: 623-630.
19. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson- Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112.
20. Tobin MD, Timpson NJ, Wain LV, Ring S, Jones LR, Emmett PM, et al. Common variation in the WNK1 gene and blood pressure in childhood: The Avon longitudinal study of parents and children. Hypertension 2008; 52: 974-979.
21. Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005; 112: 3423-3429.
22. Kokubo Y, Kamide K, Inamoto N, Tanaka C, Banno M, Takiuchi S, et al. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet 2004; 49: 507-515.
23. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, et al. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum Mol Genet 2005; 14: 1805-1814.
24. O'Reilly M, Marshall E, Speirs HJ, Brown RW. WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J Am Soc Nephrol 2003; 14: 2447-2456.
25. Delaloy C, Lu J, Houot AM, Disse-Nicodeme S, Gasc JM, Corvol P, et al. Multiple promoters in the WNK1 gene: One controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol 2003; 23: 9208-9221.
26. Hoorn EJ, Lubbe N, Zietse R. The renal WNK kinase pathway: A new link to hypertension. Nephrol Dial Transplant 2009; 24: 1074-1077.
27. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, BeltrandelRio H, et al. Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA 2003; 100: 14109-14114.
28. Fang L, Liu J, Li D, Yang CL, Subramanya AR, Maouyo D, et al. WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl Acad Sci USA 2006; 103: 8558-8563.
29. Osada Y, Miyauchi R, Goda T, Kasezawa N, Horiikel H, Iida M, et al. Variations in the WNK1 gene modulates the effect of dietary intake of sodium and potassium on blood pressure determination. J Hum Genet 2009; 54: 474-478.
30. Manunta P, Lavery J, Lanzani C, Braund PS, Simonini M, Bodycote C, et al. Physiological interaction between adducin and WNK1- NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 2008; 52: 366-372.